Landmark approval is based on results from the Phase 3 AQUILA study, showing fixed-duration treatment with daratumumab significantly reduced the risk of progression to active multiple myeloma or death ...

The Bank of Cyprus (BoC) on Wednesday announced that it has issued 8,573 new shares to members of its general management under its short-term incentive plan, according to a formal information document ...